Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
86.45
+7.02 (8.84%)
Nov 20, 2024, 4:00 PM EST - Market closed
Lantheus Holdings Employees
Lantheus Holdings had 834 employees as of December 31, 2023. The number of employees increased by 136 or 19.48% compared to the previous year.
Employees
834
Change (1Y)
136
Growth (1Y)
19.48%
Revenue / Employee
$1,794,723
Profits / Employee
$512,724
Market Cap
5.96B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 834 | 136 | 19.48% |
Dec 31, 2022 | 698 | 86 | 14.05% |
Dec 31, 2021 | 612 | 17 | 2.86% |
Dec 31, 2020 | 595 | 87 | 17.13% |
Dec 31, 2019 | 508 | 20 | 4.10% |
Dec 31, 2018 | 488 | 5 | 1.04% |
Dec 31, 2017 | 483 | 18 | 3.87% |
Dec 31, 2016 | 465 | -9 | -1.90% |
Dec 31, 2015 | 474 | -50 | -9.54% |
Dec 31, 2014 | 524 | 5 | 0.96% |
Dec 31, 2013 | 519 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Waystar Holding | 1,400 |
Inspire Medical Systems | 1,011 |
Ionis Pharmaceuticals | 927 |
Blueprint Medicines | 655 |
Halozyme Therapeutics | 373 |
Corcept Therapeutics | 352 |
Crinetics Pharmaceuticals | 290 |
Avidity Biosciences | 253 |
LNTH News
- 1 day ago - Lantheus Announces Share Repurchase Program - GlobeNewsWire
- 8 days ago - Lantheus to Present at the Jefferies London Healthcare Conference - GlobeNewsWire
- 10 days ago - Lantheus Continues to Commend CMS' CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY's Blockbuster Status for 2025 - GlobeNewsWire
- 12 days ago - Lantheus Holdings: Q3 Results Were Good But Market Overreacted - Seeking Alpha
- 14 days ago - Lantheus Holdings, Inc. (LNTH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Lantheus Applauds CMS' CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care - GlobeNewsWire
- 4 weeks ago - Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern Time - GlobeNewsWire
- 2 months ago - Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024 - GlobeNewsWire